Retrospective Analysis of Veritas in Breast Reconstruction

Baxter Healthcare Corporation54 enrolled

Overview

Retrospective data collection of the use of Veritas in breast reconstruction surgery

This is a multi-center study to retrospectively collect data on the use of Veritas Collagen Matrix in breast reconstruction. Data will be collected on post-operative complications in immediate breast reconstruction and then be compared to literature reported post-operative complication rates associated with the use of acellular dermal matrix in immediate breast reconstruction.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Seroma Necrosis Infection

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age 18 years or older * Patients who underwent mastectomy with immediate breast reconstruction using Veritas collagen matrix * Patients who underwent mastectomy with single stage procedures or two-stage procedures using Veritas collagen matrix Exclusion Criteria: * Patients who underwent delayed breast reconstruction * Reconstruction with something other than Veritas collagen matrix * Breasts that were created with DIEP or TRAM procedures

Locations (3)

Mark M. Mofid, MD

San Diego, California, United States

Michael Meininger, MD

Troy, Michigan, United States

Martin Lacey, MD

Saint Paul, Minnesota, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.